细胞周期蛋白B1
细胞凋亡
细胞周期
活力测定
细胞周期蛋白依赖激酶1
流式细胞术
细胞
甲状腺癌
细胞生长
生物
癌症研究
分子生物学
化学
甲状腺
内分泌学
生物化学
作者
Shujuan Huang,Maoxiang Cui,Rufeng Wang,Guiran Yang,Ning Wang,Lijun Cui,Guang Ma
标识
DOI:10.1080/15257770.2023.2189464
摘要
(RB) on apoptosis of papillary thyroid carcinoma cells. Our study was divided into four groups: the control group, the PV group, the RB group, and the PV combined with the RB group. The viability of cells from different treatment groups was assessed by the CCK-8 assay. Cell migration and invasion were assessed by healing wounding and the transwell assay, respectively. Cell apoptosis rate and cell cycle arrest were detected by a flow cytometry assay. The protein expression of Bcl-2, Bax, Caspase-3, CyclinA1, CyclinB1, and CDK1 was detected using a western blot assay. Our results indicated that, compared with the control group, PV combined with RB group could significantly alter the cell morphology, inhibit cell migration and invasion, decrease the number of cells in the G0/G1 phase and increase the number of cells in the G2/M phase, and promote the cell apoptosis. Moreover, PV combined with RB treatment also obviously increased the expression of Bax/Bcl2 and caspase-3 proteins and decreased the expression of Cyclin A1, Cyclin B1, and CDK1 proteins. Overall, our results indicated that PV combined with RB could activate the Bax/Bcl-2 and Caspase-3 signal pathways to induce cell apoptosis in papillary thyroid carcinoma cells; this also provides a new way to treat thyroid cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI